Karine Suissa
McGill University
11 Papers
1 Citations
Karine Suissa is an academic researcher from McGill University. The author has contributed to research in topics: Body mass index & Medicine. The author has an hindex of 3, co-authored 5 publications. Previous affiliations of Karine Suissa include Jewish General Hospital.
Chat about Author
Papers
The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review
Jamal Ait ichou,Natasha Larivée,Natasha Larivée,Mark J. Eisenberg,Karine Suissa,Karine Suissa,Kristian B. Filion +6 more
TL;DR: The objective was to evaluate the effectiveness and safety of the Impella device in high‐risk patients undergoing PCI via a systematic review of the literature.
Effects of dietary glycemic index and load on children's cardiovascular risk factors.
TL;DR: GL predicts increased BMIz, percent fat mass, and TGs and decreased HDL in young children after 2 years of follow-up, and recommendations to decrease CV risk in children should include lowering foods high in GL.
6
A mediation analysis on the relationship between dietary glycemic load, obesity and cardiovascular risk factors in children
TL;DR: The role of adiposity as a mediator in the association between dietary GL and lipid profiles after 2 years was evaluated and it was revealed that the effect of GL on blood lipids was mediated by adiposity.
1
Abstract 40: Empirical Comparison of Approaches to Mediation Analyses in Nutrition Research With Applications to the Quality Cohort
TL;DR: This work has shown that adiposity may mediate the effect of dietary glycemic load (GL) on lipid profile in children as studies have shown an association between dietary GL and adiposity and between adiposity a...
1
Obesity as a modifier of the Cardiovascular effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes.
Karine Suissa,Sebastian Schneeweiss,Antonios Douros,Hujun Yin,Elisabetta Patorno,Laurent Azoulay +5 more
TL;DR: In this article , the association between the use of sodium-glucose cotransporter-2 (SGLT2i) and cardiovascular outcomes and death as a function of obesity among patients with type 2 diabetes was assessed.